This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

This report focusses on the use of formal intellectual property rights (IPRs) and “soft IP” as the new ideas and creative expressions developed by academic researchers are put into use. It carries out a theoretical and empirical investigation of the analytical framework developed by SABIP on...